The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria

European Journal of Clinical Pharmacology

Volumn 62, Issue 12, 2006, Pages 1003-1009

  Newton, Paul N ^a,b   Barnes, Karen I ^c   Smith, Peter J ^c   Evans, Alicia C ^c   Chierakul, Wirongrong ^a   Ruangveerayuth, Ronatrai ^d   White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d MAE SOT GENERAL HOSPITAL   (Thailand)

Author keywords

Artesunate; Pharmacokinetics; Plasmodium falciparum; Severe malaria

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; QUININE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THAILAND;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCHEMISTRY; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALARIA, FALCIPARUM; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PILOT PROJECTS; QUININE; SESQUITERPENES; SEVERITY OF ILLNESS INDEX; THAILAND;

EID: 33751206523     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0203-2     Document Type: Article

References (21)

1. Angus BJ, Thaiaporn I, Chanthapadith K, Suputtamongkol Y, White NJ (2002) Oral artesunate dose-response relationship in acute falciparum malaria. Antimicrob Agents Chemother 46:778-782
2. Barradell LB, Fitton A (1995) Artesunate. Drugs 50:714-741
3. Batty K, Thu LTA, Davis TME, Ilett KF, Mai TX, Hung NC, Tien NP, Powell SM, Thien HV, Binh TQ, Kim NV (1998) A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. B J Clin Pharmacol 45:123-129
4. Bethell DB, Teja-Isavadharm P, Phuong CXT, Thuy PTT, Mai TTT, Thuy JTN, Ha NTT, Phuong PT, Kyle D, Day NJP, White NJ (1997) Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 91:195-198
5. Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T (1991) Double blind randomized clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Publ Hlth 22:543-548
6. Davis TME, Phuong HL, Ilett KF, Hung NC, Batty KT, Phuong VDB, Powell SM, Thien HV, Binh TQ (2001) Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemther 45:181-186
7. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-725
8. Hien TT, Davis TME, Chuong LV, Ilett KF, Mai NTH, Chau TTH, Agus C, Chiswell GM, White NJ, Farrar J (2004) Comparative pharmacokinetics of intramuscular artesunate and artemether in severe falciparum malaria. Antimicrob Agents Chemother 48:4234-4239
9. Li Q, Guo X, Jiang R (1982) Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Trad Chin Med 2:125-130
10. Meshnick SR, Taylor TE, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Micro Rev 60:301-315
11. Na-Bangchang K, Karbwang J, Congpoung K, Thanavibul A, Ubalee R (1998) Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate. Eur J Clin Pharmacol 53:375-376
12. Newton PN, Suputtamongkol Y, Teja-Isavadharm P, Pukrittayakamee S, Navartnam V, Bates I, White NJ (2000) Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob Agents Chemother 44:972-977
13. Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ (2003) A randomised comparison of artesunate and quinine in the treatment of severe falciparummalaria. Clin Inf Dis 37:7-16
14. Newton PN, Ward S, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ (2005) Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations. Trans Royal Soc Trop Med Hyg 100:184-186
15. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Pa Eh J, Chongsuphajaisiddhi T, White NJ (1994) Treatment of multidrug resistant falciparum malaria with a 3 day artesunate-mefloquine combination. J Infect Dis 170:971-977
16. Sangster T, Spence M, Sinclair P, Payne R, Smith C (2004) Unexpected observation of ion suppression in a liquid chromatography/atmospheric pressure chemical ionization mass spectrometric bioanalytical method. Rapid Comm Mass Spec 18:1361-1364
17. Silamut K, Hough R, Eggelte T, Pukrittayakamee S, Angus B, White NJ (1995) A simple method for assessing quinine pretreatment in acute malaria. Trans R Soc Trop Med Hyg 89:665-667
18. Souppart C, Gauducheau N, Sandrenan N, Richard F (2002) Development and validation of a HPLC-MS assay for determination of AM and DHA in human plasma. J Chrom B 774:195-203
19. White NJ (1994) Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 88 Suppl 1:S41-43
20. White NJ (1996) The treatment of malaria. N Eng J Med 335:800-806
21. White NJ (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in-vivo. Antimicrob Agents Chemother 41:1413-1422